APA (7th ed.) Citation

Ndeupen, S., Qin, Z., Jacobsen, S., Bouteau, A., Estanbouli, H., & Igyártó, B. Z. (2021). The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience, 24(12), 103479. https://doi.org/10.1016/j.isci.2021.103479

Chicago Style (17th ed.) Citation

Ndeupen, Sonia, Zhen Qin, Sonya Jacobsen, Aurélie Bouteau, Henri Estanbouli, and Botond Z. Igyártó. "The MRNA-LNP Platform's Lipid Nanoparticle Component Used in Preclinical Vaccine Studies Is Highly Inflammatory." IScience 24, no. 12 (2021): 103479. https://doi.org/10.1016/j.isci.2021.103479.

MLA (9th ed.) Citation

Ndeupen, Sonia, et al. "The MRNA-LNP Platform's Lipid Nanoparticle Component Used in Preclinical Vaccine Studies Is Highly Inflammatory." IScience, vol. 24, no. 12, 2021, p. 103479, https://doi.org/10.1016/j.isci.2021.103479.